1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective analysis of somatic and germline genetic alterations in patients with ampullary carcinomas
    Meeting Abstract

    Wong, W.; O'Reilly, E. M.; Varghese, A. M.; Yu, K. H.; Iacobuzio-Donahue, C. A.; Shia, J.; Klimstra, D.; Allen, P. J.; Lowery, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy
    Meeting Abstract

    Ng, S. P.; Liu, A.; Tao, R.; Holliday, E. B.; Brownlee, Z.; Kaseb, A. O.; Raghav, K. P. S.; Vauthey, J. N.; Minsky, B. D.; Herman, J. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 2 trial of CRS-207 and pembrolizumab in adults with recurrence of metastatic gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinomas
    Meeting Abstract

    Kelly, R. J.; Abrams, T. A.; Catenacci, D. V. T.; Wainberg, Z. A.; Lin, B. S. L.; Enstrom, A.; Whiting, C. C.; Wason, P.; Murphy, A.; Brockstedt, D. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • CheckMate 649: A randomized, multicenter, open-label, phase III study of nivolumab (NIVO) plus ipilimumab (IPI) or nivo plus chemotherapy (CTX) versus CTX alone in patients with previously untreated advanced (Adv) gastric (G) or gastroesophageal junction (GEJ) cancer
    Meeting Abstract

    Moehler, M. H.; Janjigian, Y. Y.; Adenis, A.; Aucoin, J. S.; Boku, N.; Chau, I.; Cleary, J. M.; Feeney, K.; Franke, F. A.; Mendez, G. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Krantz, B. A.; Tsui, D.; Lowery, M. A.; Capanu, M.; Yu, K. H.; Kelsen, D. P.; Gedvilaite, E.; Zhang, L.; Selcuklu, S. D.; You, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of the selective FGFR inhibitor debio 1347 in phase I study patients with FGFR genomically activated advanced biliary tract cancer (BTC)
    Meeting Abstract

    Cleary, J. M.; Voss, M. H.; Meric-Bernstam, F.; Hierro, C.; Heist, R. S.; Ishii, N.; Kirpicheva, Y.; Nicolas-Metral, V.; Pokorska-Bocci, A.; Vaslin, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I/II multi-center study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC)
    Meeting Abstract

    Giuroiu, I.; Ku, G. Y.; Leichman, L. P.; Du, K. L.; Oh, P.; Levinson, B. A.; Iqbal, S.; Thomas, C. R.; Wu, J. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase Ib/II trial of durvalumab and chemoradiation (CRT) with carboplatin/paclitaxel for esophageal and gastroesophageal junction (GEJ) adenocarcinoma
    Meeting Abstract

    Greally, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Fein, C.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Overall survival of PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Hecht, J. R.; Naing, A.; Falchook, G. S.; Patel, M. R.; Infante, J. R.; Aljumaily, R.; Wong, D. J. L.; Autio, K. A.; Wainberg, Z. A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial
    Meeting Abstract

    Abou-Alfa, G. K.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Rimassa, L.; Ryoo, B. Y.; Cicin, I.; Merle, P.; Park, J. W.; Blanc, J. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save